Samaras K - Search Results

1

Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infection.

Wand H, Calmy A, Carey DL, Samaras K, Carr A, Law MG, Cooper DA, Emery S; INITIO Trial International Coordinating Committee. Wand H, et al. Among authors: samaras k. AIDS. 2007 Nov 30;21(18):2445-53. doi: 10.1097/QAD.0b013e3282efad32. AIDS. 2007. PMID: 18025881 Clinical Trial.

2

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors.

Carr A, Samaras K, Burton S, Law M, Freund J, Chisholm DJ, Cooper DA. Carr A, et al. Among authors: samaras k. AIDS. 1998 May 7;12(7):F51-8. doi: 10.1097/00002030-199807000-00003. AIDS. 1998. PMID: 9619798

3

Pathogenesis of HIV-1-protease inhibitor-associated peripheral lipodystrophy, hyperlipidaemia, and insulin resistance.

Carr A, Samaras K, Chisholm DJ, Cooper DA. Carr A, et al. Among authors: samaras k. Lancet. 1998 Jun 20;351(9119):1881-3. doi: 10.1016/S0140-6736(98)03391-1. Lancet. 1998. PMID: 9652687 Review.

4

Obesity: genes, glands or gluttony?

Chisholm DJ, Samaras K, Markovic T, Carey D, Lapsys N, Campbell LV. Chisholm DJ, et al. Among authors: samaras k. Reprod Fertil Dev. 1998;10(1):49-53. doi: 10.1071/r98016. Reprod Fertil Dev. 1998. PMID: 9727592 Review.

5

Abnormal fat distribution and use of protease inhibitors.

Carr A, Samaras K, Chisholm DJ, Cooper DA. Carr A, et al. Among authors: samaras k. Lancet. 1998 Jun 6;351(9117):1736. doi: 10.1016/S0140-6736(05)77775-8. Lancet. 1998. PMID: 9734916 No abstract available.

6

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study.

Carr A, Samaras K, Thorisdottir A, Kaufmann GR, Chisholm DJ, Cooper DA. Carr A, et al. Among authors: samaras k. Lancet. 1999 Jun 19;353(9170):2093-9. doi: 10.1016/S0140-6736(98)08468-2. Lancet. 1999. PMID: 10382692

7

Anti-retroviral therapy, insulin resistance and lipodystrophy.

Gan SK, Samaras K, Carr A, Chisholm D. Gan SK, et al. Among authors: samaras k. Diabetes Obes Metab. 2001 Apr;3(2):67-71. doi: 10.1046/j.1463-1326.2001.00146.x. Diabetes Obes Metab. 2001. PMID: 11298728 Review. No abstract available.

8

Altered myocellular and abdominal fat partitioning predict disturbance in insulin action in HIV protease inhibitor-related lipodystrophy.

Gan SK, Samaras K, Thompson CH, Kraegen EW, Carr A, Cooper DA, Chisholm DJ. Gan SK, et al. Among authors: samaras k. Diabetes. 2002 Nov;51(11):3163-9. doi: 10.2337/diabetes.51.11.3163. Diabetes. 2002. PMID: 12401706

9

No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial.

Carr A, Workman C, Carey D, Rogers G, Martin A, Baker D, Wand H, Law M, Samaras K, Emery S, Cooper DA; Rosey investigators. Carr A, et al. Among authors: samaras k. Lancet. 2004 Feb 7;363(9407):429-38. doi: 10.1016/S0140-6736(04)15489-5. Lancet. 2004. PMID: 14962523 Clinical Trial.

10

Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases.

Samaras K, Pett S, Gowers A, McMurchie M, Cooper DA. Samaras K, et al. J Clin Endocrinol Metab. 2005 Jul;90(7):4394-8. doi: 10.1210/jc.2005-0036. Epub 2005 Mar 8. J Clin Endocrinol Metab. 2005. PMID: 15755851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

172 results

Search Page